NEW YORK (GenomeWeb) – Belgian cancer diagnostics firm OncoDNA announced yesterday that it has raised €7.7 million ($8.6 million) through a private stock placement.

Existing investors participating in the equity round included Bio.be, Invest4OncoDNA, Sambrinvest, and Vinsovier. New investors included Ackermans & van Haaren affiliate Sofinim, SRIW, CPH, and Inventures. OncoDNA said that Ackermans & van Haaren now holds a 15 percent stake in the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.